MicroRNA expression and function in cancer.
By R. Garzon, M. Fabbri, A. Cimmino, George A. Calin, Carlo Maria Croce. Trends in Molecular Medicine, 2006
809 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/6bfb963016dc6d43f5eadabd2d6df03b55deab6d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- Sam Griffiths-Jones
- Artemis G. Hatzigeorgiou
- P. Murphy
- Leigh-Ann MacFarlane
- Anton J. Enright
- Martin Reczko
- Stijn van Dongen
- Harpreet Kaur Saini
In Molecular Biology
- Sam Griffiths-Jones
- Artemis G. Hatzigeorgiou
- Stijn van Dongen
- Anton J. Enright
- P. Murphy
- Leigh-Ann MacFarlane
- Martin Reczko
- Harpreet Kaur Saini
Citations in the corpus
- MicroRNA: Biogenesis, Function and Role in Cancer (2010, background): “Dysregulation of miRNA expression profiles has been demonstrated in most tumors examined [24, 241].”
- MicroRNA signature predicts survival and relapse in lung cancer. (2008, background): “With the advent of miRNA expression profiles, significant efforts have been made to correlate miRNA expressions with tumor prognosis (Calin and Croce, 2006a, 2006b; Cummins and Velculescu, 2006; Esquela-Kerscher and Slack, 2006; Garzon et al., 2006; Gregory and Shiekhattar, 2005).”
- miRBase: tools for microRNA genomics (2007, background): “miRNAs have been implicated in processes and pathways such as development, cell proliferation, apoptosis, metabolism and morphogenesis, and in diseases including cancer (4,5).”
- Lost in translation: an assessment and perspective for computational microRNA target identification (2009, background): “Although miRNAs were first identified in 1993 (Lee et al., 1993) via classical genetic techniques in Caenorhabditis elegans, in 2001 it was suggested that they are widespread and abundant in cells (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001).”
- MicroRNA-125b is a novel negative regulator of p53. (2009, background): “Differences in miRNA expression profiles define the signatures of various cancers, and miRNA dysregulation can lead to all the hallmarks of cancer (Garzon et al. 2006; Zhang et al. 2007). miRNAs are known to be both regulators and targets of oncogenes and tumor suppressor genes (Garzon et al. 2006).”